Breast Cancer

Showing NaN - NaN of 191

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Pembrolizumab)

Not yet recruiting
  • Breast Cancer
  • Jonesboro, Arkansas
  • +142 more
Oct 31, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Duarte, California
  • +111 more
Oct 23, 2023

Toxicities of Salvage Treatment in Locoregionally Recurrent

Not yet recruiting
  • Breast Cancer
  • Salvage treatment (surgery and/or radiation therapy)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jul 5, 2023

Nipple-areolar Complex Sensation According to Incision Types in

Completed
  • Breast Cancer
  • Nipple Sparing Mastectomy
  • Nipple sparing mastecomy with different incision placements
  • Seoul, Korea, Republic of
    GangnamSeverance Hospital
Jun 15, 2023

Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul

Recruiting
  • Breast Cancer
  • +2 more
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 8, 2023

    Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer

    Recruiting
    • Breast Cancer
    • Whole breast irradiation +/- tumor bed boost
    • Seoul, Korea, Republic of
      Samsung Medical Center
    May 30, 2023

    Breast Tumors, Breast Cancer Trial in Busan, Seoul (Breast MRI for Breast Cancer Detection)

    Not yet recruiting
    • Breast Neoplasms
    • Breast Cancer
    • Breast MRI for Breast Cancer Detection
    • Busan, BusanJin-Gu, Korea, Republic of
    • +3 more
    Apr 2, 2023

    Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

    Active, not recruiting
    • Breast Cancer
    • Aurora, Colorado
    • +23 more
    Jan 30, 2023

    Breast Cancer Trial in Worldwide (Dato-DXd, Paclitaxel, Nab-paclitaxel)

    Recruiting
    • Breast Cancer
    • Duarte, California
    • +260 more
    Jan 19, 2023

    Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Capecitabine)

    Recruiting
    • Breast Cancer
    • Gilbert, Arizona
    • +165 more
    Jan 17, 2023

    A Post Marketing Surveillance on Piqray in Korea

    Recruiting
    • Breast Cancer
    • Piqray
    • Deogyang Gu Goyang Si, Gyeonggi Do, Korea, Republic of
    • +4 more
    Jan 16, 2023

    Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,

    Recruiting
    • Breast Neoplasms
    • +2 more
    • Trastuzumab Deruxtecan
    • +5 more
    • Springdale, Arkansas
    • +203 more
    Jan 13, 2023

    An Observational Study of Kadcyla Safety in Breast Cancer

    Completed
    • Breast Cancer
      • Busan, Korea, Republic of
      • +37 more
      Jan 10, 2023

      Breast Cancer Trial in Worldwide (Atezolizumab, Trastuzumab Emtansine, Placebo)

      Recruiting
      • Breast Cancer
      • Alabaster, Alabama
      • +305 more
      Jan 10, 2023

      Breast Cancer Trial in Worldwide (Inavolisib, Placebo, Palbociclib)

      Recruiting
      • Breast Cancer
      • Tucson, Arizona
      • +228 more
      Jan 10, 2023

      'OLAP' (OLAparib Regulatory Post-marketing Surveillance)

      Recruiting
      • Ovarian Cancer
      • +3 more
        • Busan, Korea, Republic of
        • +17 more
        Jan 9, 2023

        Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with

        Not yet recruiting
        • Breast Cancer
        • +4 more
        • Ovarian function suppression with endocrine treatments
        • Seoul, Korea, Korea, Republic of
          Gangnam Severance Hospital
        Dec 18, 2022

        Breast Cancer, Head Neck Cancer Trial in Seoul (Palbociclib, Cetuximab, Fulvestrant)

        Recruiting
        • Breast Cancer
        • Head and Neck Cancer
        • Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
        • +3 more
        Dec 14, 2022

        Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

        Active, not recruiting
        • Breast Cancer
        • Atlanta, Georgia
        • +19 more
        Dec 5, 2022

        Breast Cancer Trial in Worldwide (Dato-DXd, Capecitabine, Gemcitabine)

        Active, not recruiting
        • Breast Cancer
        • Duarte, California
        • +172 more
        Dec 1, 2022

        Breast Cancer Trial in Japan, Korea, Republic of, Taiwan (Tucatinib, Trastuzumab, Capecitabine)

        Active, not recruiting
        • Breast Cancer
        • Nagoya, Aichi, Japan
        • +27 more
        Nov 30, 2022

        Breast Cancer Trial in Worldwide (Olaparib, Placebo)

        Active, not recruiting
        • Breast Cancer
        • Anchorage, Alabama
        • +698 more
        Nov 25, 2022

        Breast Cancer Trial in Worldwide (Alpelisib, Fulvestrant, Letrozole)

        Active, not recruiting
        • Breast Cancer
        • Gilbert, Arizona
        • +93 more
        Nov 10, 2022

        Breast Cancer, Cholangiocarcinoma, Ovarian Cancer Trial in Worldwide (AZD8205)

        Recruiting
        • Breast Cancer
        • +3 more
        • Duarte, California
        • +12 more
        Oct 31, 2022